Publication Author: Weatherald J
Filter by Author:
Treatments for pulmonary arterial hypertension: navigating through a network of choices.
Pitre T, Weatherald J, Humbert M.
POINT: Should the Use of Upfront Triple Combination Therapy Be Standard of Care in Pulmonary Arterial Hypertension? Yes.
Weatherald J, Sitbon O.
“I Had to Know About It, I Had to Find It, I Had to Know How to Access it”: Experiences of Access to Rehabilitation Services Among People Living with Long COVID.
Hung P, Brehon K, Miciak M, Brown DA, Bostick G, Brown C, Churchill K, Hall M, Hoddinott L, Hudon A, Hunter S, Perreault K, Wieler M, Skolnik K, Lam GY, Weatherald J, Gross DP.
Randomized Trial Of Routine Versus On-demand Intraoperative Extracorporeal Membrane Oxygenation In Lung Transplantation: A Feasibility Study.
Nasir B, Weatherald J, Ramsay T, Cypel M, Donahoe L, Durkin C, Schisler T, Nagendran J, Liberman M, Landry C, Overbeek C, Moore A, Ferraro P.
Real-world evidence to advance knowledge in pulmonary hypertension: Status, challenges, and opportunities. A consensus statement from the Pulmonary Vascular Research Institute’s Innovative Drug Development Initiative’s Real-world Evidence Working Group.
Morland K, Gerges C, Elwing J, Visovatti SH, Weatherald J, Gillmeyer KR, Sahay S, Mathai SC, Boucly A, Williams PG, Harikrishnan S, Minty EP, Hobohm L, Jose A, Badagliacca R, Lau EMT, Jing ZC, Vanderpool RR, Fauvel C, Leonidas Alves J Jr, Strange G, Pulido T, Qian J, Li M, Mercurio V, Zelt JGE, Moles VM, Cirulis MM, Nikkho SM, Benza RL, Elliott CG.
“None of us are lying”: an interpretive description of the search for legitimacy and the journey to access quality health services by individuals living with Long COVID.
Brehon K, Miciak M, Hung P, Chen SP, Perreault K, Hudon A, Wieler M, Hunter S, Hoddinott L, Hall M, Churchill K, Brown DA, Brown CA, Bostick G, Skolnik K, Lam G, Weatherald J, Gross DP.
Ambitions for Pulmonary Arterial Hypertension Composite End Points: A Chain Is Only as Strong as Its Weakest Link.
Zelt JGE, Weatherald J, Mathai SC.
Systemic corticosteroids for outpatient respiratory viral infections in lung transplant recipients
Ghandi V, Li D, Weinkauf J, Lien D, Hirji A, Varughese R, Weatherald J, Sligl W, Kabbani D, Schwartz I, Doucette K, Cervera C, Halloran K.
Win Statistics in Pulmonary Arterial Hypertension Clinical Trials.
Weatherald J, Moutchia J, Al-Naamani N, McClelland RL, Ventetuolo CE, Palevsky HI, Harhay MO, Kawut SM.
Esophageal motility in systemic sclerosis before and after autologous hematopoietic cell transplantation.
Woo MMK, Levin D, Li DY, David J, Buresi M, Gupta M, Nasser Y, Andrews CN, Durand C, Osman MS, Jamani K, Weatherald J, Johannson KA, Howlett JG, Hemmati I, Kim H, Curley M, Storek J.
Reducing the pressure in PAH: Sotatercept, hemodynamics, and the right ventricle.
Price LC, McCabe C, Weatherald J.
Awake prone position in patients with acute hypoxic respiratory failure: A narrative review.
Duhailib ZA, Parhar KKS, Solverson K, Alhazzani W, Weatherald J.
Treatment of pulmonary arterial hypertension: recent progress and a look to the future.
Humbert M, Sitbon O, Guignabert C, Savale L, Boucly A, Gallant-Dewavrin M, McLaughlin V, Hoeper MM, Weatherald J.
Association Between the Pulmonary Artery Pulsatility Index and Prognosis in Pulmonary Arterial Hypertension: A Multicentre Study.
Ostad S, Sugarman J, Alkhodair A, Liang J, Mielniczuk LM, Hambly N, Helmersen D, Hirani N, Thakrar M, Varughese R, Norena M, Kularatne M, Swiston JR, Kapasi A, Weatherald J, Brunner NW.
Patients’ perceptions on clinical trials outcomes in pulmonary arterial hypertension therapy.
Mai V, Gosselin C, Tremblay E, Rompré G, Lajoie AC, Weatherald J, Lega JC, Bonnet S, Provencher S.
Management of Pulmonary Arterial Hypertension.
Weatherald J, Varughese RA, Liu J, Humbert M.
Illuminating the Importance of Pulmonary Arterial Compliance in Pulmonary Hypertension.
Weatherald J, Zanini U, Humbert M.
The new 2022 pulmonary hypertension guidelines: some small steps and some giant leaps forward for evidence-based care.
Price LC, Weatherald J.
Priorities for pulmonary hypertension research: A James Lind Alliance priority setting partnership.
Weatherald J, Iqbal H, Mielniczuk L, Syed AR, Legkaia L, Howard J, Dempsey N, Rader T, Swiston J, Provencher S.
